Shopping Cart
- Remove All
- Your shopping cart is currently empty
LSD1-IN-13 (compound 7e) is an orally active LSD1 inhibitor (IC50: 24.43 nM) that activates CD86 expression (EC50: 470 nM) and induces differentiation of AML (acute myeloid leukaemia) cell lines.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,140 | 6-8 weeks | |
50 mg | $2,785 | 6-8 weeks | |
100 mg | $3,520 | 6-8 weeks |
Description | LSD1-IN-13 (compound 7e) is an orally active LSD1 inhibitor (IC50: 24.43 nM) that activates CD86 expression (EC50: 470 nM) and induces differentiation of AML (acute myeloid leukaemia) cell lines. |
Molecular Weight | 411.56 |
Formula | C23H29N3O2S |
Cas No. | 2170212-33-4 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.